InterCure Ltd

The potential rescheduling of cannabis in the U.S. and the growing demand in Germany positions InterCure (NASDAQ: INCR), the leading seller of pharmaceutical cannabis outside North America, to capitalize on these opportunities, according to a recent initiation note by Pablo Zuanic of Zuanic...

InterCure Ltd. (NASDAQ:INCR) achieved significant financial success in FY2023, reporting a total revenue of approximately $95.2 million. The company showcased an adjusted EBITDA of around $16.3 million, representing 17% of its total revenues. This performance marks an improvement over the...

Subversive Real Estate Acquisition REIT LP (OTCQX: SBVRF) (NEO: SVX.U) is teaming up with Israeli cannabis company InterCure Ltd. “We are excited to announce today’s qualifying transaction, which, upon closing, will allow our shareholders to participate in the upside of the Israeli...